发明名称 ANVENDELSE AF GLU-TUBULIN SOM BIOMARKØR FOR LÆGEMIDDELRESPONS PÅ FURAZANOBENZIMIDAZOLER
摘要 Use of glu-tubulin as a biomarker for predicting the response to a compound, preferably resistance of a disease such as cancer in a subject to said compound, wherein the compound is a furazanobenzimidazole compound of general formula (I).
申请公布号 DK2666014(T3) 申请公布日期 2017.01.09
申请号 DK20120700494T 申请日期 2012.01.19
申请人 Basilea Pharmaceutica AG 发明人 LANE, Heidi Alexandra;BACHMANN, Felix
分类号 G01N33/68;A61K31/4245;G01N33/50 主分类号 G01N33/68
代理机构 代理人
主权项
地址